Firm Pays $650 Million Settlement For Role In Fueling U.S. Opioid Crisis
McKinsey & Company, a global consulting firm that played a key role in promoting OxyContin sales during the opioid epidemic, has agreed to pay a $650 million settlement as part of a deferred prosecution agreement with the Department of Justice (DOJ),
‘Source Of Profound Regret’: Firm Pays Half Billion Settlement To Avoid Criminal Prosecution For Fueling Opioid Crisis
A consulting giant that helped fuel the United States’ deadly opioid epidemic agreed to pay a massive settlement to avoid
McKinsey to Pay $650 Million in Opioid Settlement With Justice Department
McKinsey & Company has agreed to pay $650 million to settle a Justice Department investigation of its work with the opioid maker Purdue Pharma. A former senior partner has also agreed to plead guilty to obstruction of justice for destroying internal company records in connection with that work.
McKinsey to pay $650 million after advising opioid maker on how to 'turbocharge' sales
McKinsey & Company agreed to pay $650 million to resolve criminal and civil investigations into its advice to opioids manufacturer Purdue Pharma.
Consulting giant McKinsey to pay $650M to settle DOJ criminal opioid probe
Prosecutors said that McKinsey provided Stamford, Conn.-based Purdue advice on measures it could take to “turbocharge” OxyContin sales.
McKinsey to pay $650 million over role in OxyContin epidemic
International consulting firm McKinsey & Company agreed Friday to resolve criminal charges with federal prosecutors in two states for its role in helping Purdue Pharma boost sales of OxyContin and other opioid painkillers,
McKinsey to pay $650 million for role in opioid crisis
Global consulting firm McKinsey & Company Inc. agreed to pay $650 million to resolve a criminal and civil investigation into the firm's work with opioid maker
McKinsey to pay $650 mn to settle US criminal case on opioids
Consulting giant McKinsey & Company will pay $650 million to settle US criminal charges that it collaborated with Purdue Pharma to intentionally misbrand opioids, worsening a public health crisis, officials announced Friday.
McKinsey & Company to pay $650 million for role in opioid crisis
The powerful consulting firm McKinsey will "accept responsibility" and pay $650 million for helping to fuel the opioid crisis, but executives will once again dodge prosecution.
The Economist16h
Is the opioid epidemic finally burning out?
The epidemic may simply be “burning out”, suggests Professor ... But in the short term, it is cheap and lasts a long time, ...
CNN on MSN1d
Consulting firm McKinsey to pay $650 million to resolve US criminal opioid probe
McKinsey previously reached agreements totaling nearly $1 billion to settle widespread lawsuits and other legal actions ...
emjreviews.com3h
Brain Imaging Reveals Key Changes in Opioid Use Disorder Patients – RSNA 2024
A NOVEL study from the USA presented at the Radiological Society of North America (RSNA), reveals significant structural and ...
Courthouse News Service1d
In prosecution first, consultants on hook for $650 million for role in opioid epidemic
The agreement marks the first time a management consulting firm has been held criminally responsible for advice resulting in ...
Psychology Today4d
Opioid Epidemic Leaves Collective Grief and a Burdened Generation
The opioid epidemic has resulted in a legion of survivors who struggle with guilt and grief that is not always being ...
Hosted on MSN13h
Dolphins becoming hooked on deadly opioid as scientists issue urgent warning
Scientists have found the opioid in the bodies of more than 20 percent of bottlenose dolphins tested in the waters.
Economist breaks down Baltimore’s $5 billion opioid crisis plan
An economist explained why Baltimore’s $5 billion plan to tackle the opioid crisis costs so much in his testimony Thursday.